Latest News

Tesla's sales have struggled but the stock is up, so what the future for Tesla stock?

The technology giant has multiple irons in the fire.

Why the dividend investor may take a look at UNITED PARCEL SERVICE-CL B (NYSE:UPS).

Orchid Research flags Indigo, Oil India, and Angel One as trade opportunities based on strong technical setups. Resistance breakouts could drive near-term gains in these stocks.

Indian equity markets surged to a seven-month high on Thursday, driven by heavyweights and U.S.-India trade deal optimism.

Looking for a safe place to stash your money during a downturn? Open a high-yield savings account for flexibility, safety, and strong returns.

Gold price falls for a second straight day and is 10% down from its all-time high.

A fundamental and technical analysis of (NASDAQ:CPRX): Why CATALYST PHARMACEUTICALS INC (NASDAQ:CPRX) is Poised for High Growth.

CoreWeave becomes the first to deploy Nvidia's cutting-edge GB200 Grace Blackwell systems at scale during the first quarter of 2025.

Rep. Larson questioned the Joint Committee on Taxation Chief of Staff about the new Republican tax bill and its impact on Social Security taxes, showing that it may not fulfill President Trump's promise of no taxes on Social Security.

AUD/JPY falls amid expectations of further BoJ interest rate hikes in 2025; optimism over a potential US-Japan trade deal.

This drugmaker achieved a milestone - its first quarterly profit. But the stock is down despite the good tidings.

Interesting Technical Analysis finding for PROTAGONIST THERAPEUTICS INC (NASDAQ:PTGX): Indications Suggest NASDAQ:PTGX Could Be on the Verge of a Breakout.